Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Urol Nefrol (Mosk) ; (5): 20-3, 1995.
Article in Russian | MEDLINE | ID: mdl-8571477

ABSTRACT

17 exacerbation and 13 latent CBP cases received ciprofloxacin in a dose 500 mg twice a day orally for 6-34 days. At pretreatment microbiological investigation of the prostatic juice 49 cultures of 7 microorganism species were isolated (12 cases of monoculture, 18 cases of 2-component associations). S. epidermidis and E. faecalis occurred more frequently (in 29.4 and 25%, respectively). Ciprofloxacin was highly active against all the isolated agents and by the number of sensitive to it strains proved superior to control antimicrobial drugs. Good and satisfactory treatment outcomes were achieved in 76.8% of patients. Side effects recorded in 8 patients (26.6%) caused the drug undue discontinuation in 1 patient only.


Subject(s)
Anti-Infective Agents/therapeutic use , Bacterial Infections/drug therapy , Ciprofloxacin/therapeutic use , Prostatitis/drug therapy , Adult , Anti-Infective Agents/adverse effects , Anti-Infective Agents/pharmacology , Bacteria/drug effects , Bacteria/isolation & purification , Bacterial Infections/microbiology , Bacteriuria/drug therapy , Bacteriuria/microbiology , Chronic Disease , Ciprofloxacin/adverse effects , Ciprofloxacin/pharmacology , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Prostate/metabolism , Prostate/microbiology , Prostatitis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...